In cardiometabolic health, lifecycle is the engine that converts an enrolled member into an adherent one – and it must trigger from device data, care milestones, and real behavior, not a calendar. We build CRM and lifecycle programs connected to your clinical and behavioral signals, with messaging that respects the disease and remains compliant.
The Challenge
Your lifecycle follows a calendar, not the member's real state
Most cardiometabolic lifecycle programs are time-based drips – day 1, day 3, day 7 emails – when the member's clinical and behavioral state is what should drive the message. A member who stopped scanning their CGM three days ago and a member crushing their glucose targets get the same day-7 email, and both are wrong. Lifecycle that ignores the device and behavioral signal you already collect leaves your single biggest retention lever unused.
Your CRM data is fragmented across clinical, device, and marketing silos
Diabetes companies sit on rich data – CGM readings, app engagement, care-team interactions, claims – but it lives in separate systems that do not talk. The clinical platform does not know what marketing sent, and the CRM does not know the member's last glucose reading. Without a unified member view, you cannot trigger the right message at the right moment, and every lifecycle idea dies in a data-integration problem nobody owns.
Getting chronic-disease messaging wrong causes real damage to trust
A cheery 'You're doing great!' to a member whose numbers are trending badly, or a nagging adherence nudge to someone going through a hard week, does not just underperform – it erodes the trust a chronic-disease relationship depends on. Generic marketing tone applied to diabetes management reads as tone-deaf, and members disengage from a program that clearly does not understand their reality. The stakes on message quality are higher here than in any consumer category.
Each automated health message creates a compliance surface
Lifecycle messages in cardiometabolic can drift into clinical claims, PHI handling, and consent territory fast. An automated journey that references a member's glucose data or implies a clinical outcome touches HIPAA and claim-substantiation rules that a generic marketing CRM was never built for. Teams either freeze lifecycle to avoid the risk, or run it loosely and create exposure – both of which cost you the retention lift a compliant program would deliver.
How We Support You
We begin by creating a unified member view, because without it, nothing else works. We map your clinical, device, engagement, and CRM data, then build the connective layer that allows lifecycle to trigger from real signals – last CGM scan, care milestone, adherence trend, app behavior – instead of a calendar. Addressing the data-integration challenge that typically derails lifecycle ideas is the foundation, so it is where we begin rather than where we stall.
Next, we redesign lifecycle around the member's state. Journeys respond to what the member is actually doing: a scanning lapse launches a recovery sequence, a care milestone prompts the next appropriate nudge, and a strong stretch is reinforced. This is lifecycle driven by behavioral and clinical signals, the kind that can truly improve 90-day adherence, rather than a drip that treats all members the same. The device and behavioral data you already gather becomes the engine.
We create messaging for the disease, not for the funnel. Every sequence recognizes that this is a chronic-condition relationship – honest, supportive, aligned with the member's actual trajectory, and never the tone-deaf cheerleading or nagging that weakens trust. Message quality matters more in cardiometabolic health than almost anywhere else, and we approach it as clinical-grade communication rather than marketing copy.
We design compliance into the system instead of adding it afterward. Alongside your regulatory and privacy partners, we establish how lifecycle manages PHI, consent, and claims, allowing device-triggered journeys to use real member data safely. That enables you to operate the personalized, signal-driven program that works, rather than sidelining lifecycle out of fear.
What sets us apart is that we work as lifecycle engineers within the regulated reality, linked to your growth product and experimentation efforts so lifecycle, product, and paid all support the same adherence goal. The result is a unified member view, behavior-triggered journeys, compliant messaging infrastructure, and a testing cadence your team can operate.
What we deliver
- Unified member view connecting clinical, device, engagement, and CRM data
- Behavior- and clinical-signal-triggered lifecycle journeys tied to adherence
- Disease-appropriate messaging calibrated to member trajectory
- Compliant PHI, consent, and claim handling built into the lifecycle system
- Lifecycle testing rhythm connected to your growth product and experimentation work
In cardiometabolic lifecycle, every message should be triggered by the member's clinical and behavioral state – not by a calendar. The device data you already gather is the most powerful retention engine you are not putting to work.
Our Methodology
We deliver a 90-day build. During days 1-30, we map and unify member data – clinical, device, engagement, CRM – and establish rules for PHI, consent, and claims with your privacy and regulatory partners. In days 31-60, we design and launch the first behavior-triggered journeys, beginning with high-leverage moments such as scan lapses and early adherence risk. During days 61-90, we test and improve the journeys against adherence, then transfer the system and operating cadence to your team.
Unlike a generic CRM or email agency, we build lifecycle around clinical and device signals rather than a calendar, while treating message quality and compliance as first-order concerns in a chronic-disease relationship. A conventional lifecycle firm launches a time-based drip through a marketing CRM; we connect journeys to the data that actually predicts retention and make them safe to operate using real member health data.
The program is designed for your team to own. By day 90, the unified member view, journey library, and compliance framework belong to you. We prefer to build a lifecycle engine your team operates rather than create an ongoing dependency for campaign execution.
Our Working Model
The opening 30 days focus on the unglamorous but critical work of unifying member data and establishing compliance rules. By the close of month one, you will have a functioning member view that links device and clinical signals to your CRM – often the first time lifecycle can trigger from something other than a calendar.
We provide a lifecycle operator, along with data and analytics support, to create the member view and journeys. From your side, we need a data or engineering partner to connect the systems, your CRM owner, and access to privacy and regulatory reviewers who can define the PHI and claims rules. Data integration is the make-or-break factor, which makes that engineering partnership essential.
The operating cadence is a weekly lifecycle review – which journeys are running, how they perform against adherence, and what launches next – with tests matched to your member volume. Lifecycle findings flow into your growth product and experimentation efforts, helping the entire retention program work together instead of through silos.
Engagements generally last three to six months. At the end, you have a unified member view, a collection of behavior-triggered journeys, compliant messaging infrastructure, and a team equipped to run the program. Many clients continue to extend journeys into new conditions or add deeper personalization.
- 90-day adherence improvement
- Reduced scan and logging lapse
- Unified member data foundation
- Compliant, signal-driven lifecycle
If your diabetes & cardiometabolic health company needs lifecycle & crm leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a lifecycle and CRM engagement cost for a cardiometabolic company?
The engagement uses a monthly fee across a three-to-six-month build, priced below the cost of assembling a complete lifecycle team plus the data-integration and compliance work required in this category. The biggest variable is your data's condition: when clinical, device, and CRM systems are deeply siloed, unification requires more work.
How soon will we see results from a lifecycle engagement?
The first behavior-triggered journeys typically launch near the end of month one, once the member view is in place, and early gains from lapse-recovery moments appear within weeks. The primary metric – 90-day adherence – requires a full cohort to assess, so meaningful retention signals emerge in month three or four.
How does your lifecycle team work with our current data and marketing staff?
We embed with and collaborate directly with your data or engineering partner to unify the member view, your CRM owner to create the journeys, and your privacy and regulatory reviewers to define compliance rules. Lifecycle insights flow into your growth product and experimentation work, making retention a shared initiative rather than an isolated email program.
How do you ensure automated lifecycle messages comply with HIPAA and claim rules?
We establish the compliance framework at the outset with your privacy and regulatory partners – defining how journeys manage PHI, consent, and any wording involving clinical claims – and embed those requirements into the lifecycle system rather than adding them later. This allows device-triggered journeys to safely use real member data, making signal-driven lifecycle possible instead of avoiding it out of fear.
What differentiates Winston Francois from a conventional CRM or email agency?
A conventional CRM agency delivers a time-based drip through a marketing platform. We create lifecycle around clinical and device signals, approach message quality as clinical-grade within a chronic-disease relationship, and make the entire system safe to operate with real member health data.
How is ROI measured for a lifecycle engagement?
We evaluate it through adherence and retention – 90-day adherence, fewer scan and logging lapses, and the downstream impact on the clinical outcomes and payer renewals that underpin your economics. We establish baselines at the beginning and assess journeys by cohort, while also measuring the reduction in costly human outreach enabled by a well-built lifecycle program. The goal is lasting retention, not open rates.
Which type of cardiometabolic company is best suited to this service?
The strongest fit is a Series A through growth-stage diabetes or cardiometabolic company with an established member base, device or behavioral data, and a retention challenge that a calendar-based drip cannot address. If you have very few members or do not yet have behavioral data, signal-driven lifecycle is too early, and we will say so. The first step is a call to review your data, retention curve, and where lifecycle can improve adherence.
